(S (NP (NP (JJ Adverse) (NN drug) (NNS reactions)) (-LRB- -LRB-) (NP (NNS ADRs)) (-RRB- -RRB-)) (VP (VBP are) (NP (NP (JJ big) (NN concern)) (PP (IN for) (NP (JJ public) (NN health))))) (. .))
(S (NP (NNS ADRs)) (VP (VBP are) (NP (NP (CD one)) (PP (IN of) (NP (JJS most) (JJ common) (NNS causes))) (S (VP (TO to) (VP (VB withdraw) (NP (DT some) (NNS drugs)) (PP (IN from) (NP (NNS markets)))))))) (. .))
(S (ADVP (RB Now)) (NP (NP (CD two) (JJ major) (NNS methods)) (PP (IN for) (S (VP (VBG detecting) (NP (NNS ADRs)))))) (VP (VBP are) (NP (NP (NML (JJ spontaneous) (NN reporting)) (NN system) (PRN (-LRB- -LRB-) (NP (NNP SRS)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN prescription) (NN event) (NN monitoring) (PRN (-LRB- -LRB-) (NP (NN PEM)) (-RRB- -RRB-))))) (. .))
(S (NP (NP (DT The) (NNP World) (NNP Health) (NNP Organization)) (-LRB- -LRB-) (NP (WP WHO)) (-RRB- -RRB-)) (VP (VBZ defines) (NP (NP (DT a) (NN signal)) (PP (IN in) (NP (NN pharmacovigilance)))) (PP (IN as) (`` ") (NP (NP (DT any) (JJ reported) (NN information)) (PP (IN on) (NP (NP (NP (DT a) (JJ possible) (JJ causal) (NN relationship)) (PP (IN between) (NP (NP (DT an) (JJ adverse) (NN event)) (CC and) (NP (DT a) (NN drug))))) (, ,) (NP (NP (DT the) (NN relationship)) (VP (VBG being) (ADJP (ADJP (JJ unknown)) (CC or) (ADJP (RB incompletely) (VBN documented))))))) (ADVP (RB previously))) ('' "))) (. .))
(S (PP (IN For) (NP (JJ spontaneous) (NN reporting) (NNS systems))) (, ,) (NP (JJ many) (NML (NN machine) (NN learning)) (NNS methods)) (VP (VBP are) (VP (VBN used) (S (VP (TO to) (VP (VB detect) (NP (NP (NNS ADRs)) (, ,) (PP (JJ such) (IN as) (NP (NP (NML (JJ Bayesian) (NN confidence)) (NN propagation) (JJ neural) (NN network) (PRN (-LRB- -LRB-) (NP (NN BCPNN)) (-RRB- -RRB-))) (, ,) (NP (NN decision) (NN support) (NNS methods)) (, ,) (NP (JJ genetic) (NNS algorithms)) (, ,) (NP (ADJP (NN knowledge) (VBN based)) (NNS approaches)))) (, ,) (ADVP (FW etc.)))))))) (. .))
(S (NP (CD One) (NN limitation)) (VP (VBZ is) (NP (DT the) (NN reporting) (NN mechanism) (S (VP (TO to) (VP (VB submit) (NP (NP (NN ADR) (NNS reports)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ has) (NP (JJ serious) (NN underreporting))) (CC and) (VP (VBZ is) (RB not) (ADJP (JJ able) (S (VP (TO to) (ADVP (RB accurately)) (VP (VB quantify) (NP (DT the) (VBG corresponding) (NN risk)))))))))))))))) (. .))
(S (NP (DT Another) (NN limitation)) (VP (VBZ is) (ADJP (JJ hard) (S (VP (TO to) (VP (VB detect) (NP (NNS ADRs)) (PP (IN with) (NP (NP (JJ small) (NN number)) (PP (IN of) (NP (NP (NNS occurrences)) (PP (IN of) (NP (NP (DT each) (NML (NN drug) (HYPH -) (NN event)) (NN association)) (PP (IN in) (NP (DT the) (NN database)))))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (NP (PRP we)) (VP (VBP propose) (NP (NN feature) (NN selection) (NN approach)) (S (VP (TO to) (VP (VB detect) (NP (NNS ADRs)) (PP (IN from) (NP (DT The) (NML (NNP Health) (NNP Improvement) (NNP Network) (PRN (-LRB- -LRB-) (ADJP (JJ THIN)) (-RRB- -RRB-))) (NN database))))))) (. .))
(S (ADVP (RB First)) (NP (NP (DT a) (NN feature) (NN matrix)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ represents) (NP (DT the) (JJ medical) (NNS events)) (PP (PP (IN for) (NP (NP (DT the) (NNS patients)) (ADVP (RB before)))) (CC and) (PP (IN after) (S (VP (VBG taking) (NP (NNS drugs))))))))) (, ,)) (VP (VBZ is) (VP (VBN created) (PP (IN by) (S (VP (VP (VBG linking) (NP (NP (NNS patients) (POS ')) (NNS prescriptions))) (CC and) (VP (VBG corresponding) (NP (JJ medical) (NNS events)) (ADVP (RB together)))))))) (. .))
(S (ADVP (RB Then)) (NP (JJ significant) (NNS features)) (VP (VBP are) (VP (VBN selected) (PP (VBN based) (PP (IN on) (NP (NN feature) (NN selection) (NNS methods)))) (, ,) (S (VP (VBG comparing) (NP (DT the) (NN feature) (NN matrix)) (SBAR (IN before) (S (NP (NNS patients)) (VP (VBP take) (NP (NNS drugs)) (PP (IN with) (NP (CD one))) (SBAR (IN after) (S (NP (NNS patients)) (VP (VBP take) (NP (NNS drugs)))))))))))) (. .))
(S (ADVP (RB Finally)) (NP (DT the) (JJ significant) (NNS ADRs)) (VP (MD can) (VP (VB be) (VP (VBN detected) (PP (IN from) (NP (NP (NNS thousands)) (PP (IN of) (NP (JJ medical) (NNS events))))) (PP (VBN based) (PP (IN on) (NP (VBG corresponding) (NNS features))))))) (. .))
(S (NP (NNS Experiments)) (VP (VBP are) (VP (VBN carried) (PRT (RP out)) (PP (IN on) (NP (DT the) (NN drug) (NN Atorvastatin))))) (. .))
(S (NP (JJ Good) (NN performance)) (VP (VBZ is) (VP (VBN achieved))) (. .))
